Selected research
Industry Research
Cevimeline Industry Research Report 2026
Market perspective
The global Cevimeline market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cevimeline is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cevimeline is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cevimeline is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cevimeline include Rubicon Research, Rising Pharma Holdings, Inc., Macleods Pharmaceuticals Limited, Lupin, Hikma Pharmaceuticals, Daiichi Sankyo, Cosette Pharmaceuticals, Bryant Ranch Prepack and Bionpharma Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cevimeline market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cevimeline Market by Company
Rubicon Research
Rising Pharma Holdings, Inc.
Macleods Pharmaceuticals Limited
Lupin
Hikma Pharmaceuticals
Daiichi Sankyo
Cosette Pharmaceuticals
Bryant Ranch Prepack
Bionpharma Inc
Aurobindo Pharma
Cevimeline Segment by Type
NDA
ANDA
Cevimeline Segment by Application
Retail Pharmacies
Hospitals
Clinics
Cevimeline Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cevimeline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cevimeline and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cevimeline.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cevimeline manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cevimeline by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cevimeline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- NDA
- ANDA
Applications
- Retail Pharmacies
- Hospitals
- Clinics
Companies covered
- Rubicon Research
- Rising Pharma Holdings, Inc.
- Macleods Pharmaceuticals Limited
- Lupin
- Hikma Pharmaceuticals
- Daiichi Sankyo
- Cosette Pharmaceuticals
- Bryant Ranch Prepack
- Bionpharma Inc
- Aurobindo Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cevimeline Market Size (2021-2032)
- 2.2.2 Global Cevimeline Sales (2021-2032)
- 2.2.3 Global Cevimeline Market Average Price (2021-2032)
- 2.3 Cevimeline by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 NDA
- 2.3.3 ANDA
- 2.4 Cevimeline by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Hospitals
- 2.4.4 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cevimeline Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cevimeline Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Cevimeline Revenue of Manufacturers (2021-2026)
- 3.4 Global Cevimeline Average Price by Manufacturers (2021-2026)
- 3.5 Global Cevimeline Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cevimeline, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cevimeline, Product Type & Application
- 3.8 Global Manufacturers of Cevimeline, Established Date
- 3.9 Global Cevimeline Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Rubicon Research
- 4.1.1 Rubicon Research Company Information
- 4.1.2 Rubicon Research Business Overview
- 4.1.3 Rubicon Research Cevimeline Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Rubicon Research Cevimeline Product Portfolio
- 4.1.5 Rubicon Research Recent Developments
- 4.2 Rising Pharma Holdings, Inc.
- 4.2.1 Rising Pharma Holdings, Inc. Company Information
- 4.2.2 Rising Pharma Holdings, Inc. Business Overview
- 4.2.3 Rising Pharma Holdings, Inc. Cevimeline Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Rising Pharma Holdings, Inc. Cevimeline Product Portfolio
- 4.2.5 Rising Pharma Holdings, Inc. Recent Developments
- 4.3 Macleods Pharmaceuticals Limited
- 4.3.1 Macleods Pharmaceuticals Limited Company Information
- 4.3.2 Macleods Pharmaceuticals Limited Business Overview
- 4.3.3 Macleods Pharmaceuticals Limited Cevimeline Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Macleods Pharmaceuticals Limited Cevimeline Product Portfolio
- 4.3.5 Macleods Pharmaceuticals Limited Recent Developments
- 4.4 Lupin
- 4.4.1 Lupin Company Information
- 4.4.2 Lupin Business Overview
- 4.4.3 Lupin Cevimeline Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lupin Cevimeline Product Portfolio
- 4.4.5 Lupin Recent Developments
- 4.5 Hikma Pharmaceuticals
- 4.5.1 Hikma Pharmaceuticals Company Information
- 4.5.2 Hikma Pharmaceuticals Business Overview
- 4.5.3 Hikma Pharmaceuticals Cevimeline Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hikma Pharmaceuticals Cevimeline Product Portfolio
- 4.5.5 Hikma Pharmaceuticals Recent Developments
- 4.6 Daiichi Sankyo
- 4.6.1 Daiichi Sankyo Company Information
- 4.6.2 Daiichi Sankyo Business Overview
- 4.6.3 Daiichi Sankyo Cevimeline Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Daiichi Sankyo Cevimeline Product Portfolio
- 4.6.5 Daiichi Sankyo Recent Developments
- 4.7 Cosette Pharmaceuticals
- 4.7.1 Cosette Pharmaceuticals Company Information
- 4.7.2 Cosette Pharmaceuticals Business Overview
- 4.7.3 Cosette Pharmaceuticals Cevimeline Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cosette Pharmaceuticals Cevimeline Product Portfolio
- 4.7.5 Cosette Pharmaceuticals Recent Developments
- 4.8 Bryant Ranch Prepack
- 4.8.1 Bryant Ranch Prepack Company Information
- 4.8.2 Bryant Ranch Prepack Business Overview
- 4.8.3 Bryant Ranch Prepack Cevimeline Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bryant Ranch Prepack Cevimeline Product Portfolio
- 4.8.5 Bryant Ranch Prepack Recent Developments
- 4.9 Bionpharma Inc
- 4.9.1 Bionpharma Inc Company Information
- 4.9.2 Bionpharma Inc Business Overview
- 4.9.3 Bionpharma Inc Cevimeline Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bionpharma Inc Cevimeline Product Portfolio
- 4.9.5 Bionpharma Inc Recent Developments
- 4.10 Aurobindo Pharma
- 4.10.1 Aurobindo Pharma Company Information
- 4.10.2 Aurobindo Pharma Business Overview
- 4.10.3 Aurobindo Pharma Cevimeline Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Aurobindo Pharma Cevimeline Product Portfolio
- 4.10.5 Aurobindo Pharma Recent Developments
5 Global Cevimeline Market Scenario by Region
- 5.1 Global Cevimeline Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cevimeline Sales by Region: 2021-2032
- 5.2.1 Global Cevimeline Sales by Region: 2021-2026
- 5.2.2 Global Cevimeline Sales by Region: 2027-2032
- 5.3 Global Cevimeline Revenue by Region: 2021-2032
- 5.3.1 Global Cevimeline Revenue by Region: 2021-2026
- 5.3.2 Global Cevimeline Revenue by Region: 2027-2032
- 5.4 North America Cevimeline Market Facts & Figures by Country
- 5.4.1 North America Cevimeline Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cevimeline Sales by Country (2021-2032)
- 5.4.3 North America Cevimeline Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Cevimeline Market Facts & Figures by Country
- 5.5.1 Europe Cevimeline Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cevimeline Sales by Country (2021-2032)
- 5.5.3 Europe Cevimeline Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Cevimeline Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cevimeline Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cevimeline Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cevimeline Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cevimeline Market Facts & Figures by Country
- 5.7.1 South America Cevimeline Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cevimeline Sales by Country (2021-2032)
- 5.7.3 South America Cevimeline Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Cevimeline Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cevimeline Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cevimeline Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cevimeline Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Cevimeline Sales by Type (2021-2032)
- 6.1.1 Global Cevimeline Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Cevimeline Sales Market Share by Type (2021-2032)
- 6.2 Global Cevimeline Revenue by Type (2021-2032)
- 6.2.1 Global Cevimeline Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cevimeline Revenue Market Share by Type (2021-2032)
- 6.3 Global Cevimeline Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cevimeline Sales by Application (2021-2032)
- 7.1.1 Global Cevimeline Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Cevimeline Sales Market Share by Application (2021-2032)
- 7.2 Global Cevimeline Revenue by Application (2021-2032)
- 7.2.1 Global Cevimeline Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cevimeline Revenue Market Share by Application (2021-2032)
- 7.3 Global Cevimeline Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cevimeline Value Chain Analysis
- 8.1.1 Cevimeline Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cevimeline Production Mode & Process
- 8.2 Cevimeline Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cevimeline Distributors
- 8.2.3 Cevimeline Customers
9 Global Cevimeline Analyzing Market Dynamics
- 9.1 Cevimeline Industry Trends
- 9.2 Cevimeline Industry Drivers
- 9.3 Cevimeline Industry Opportunities and Challenges
- 9.4 Cevimeline Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst